Major depression is emerging as a disease of the central nervous system with a characteristic pathophysiology. For inpatients with major depression, the lifetime mortality due to suicide reaches 15%. Despite a global burden of neuropsychiatric disorders on individual mental health and society's productivity, little is known on mechanisms or molecules that are responsible for these diseases. Accordingly, the identification of the neurobiological underpinnings for mood disorders represents an important challenge in neuropsychiatric research. Complex polygenic mechanisms are likely, with environmental factors contributing to the development of depression and suicidal behavior. However, research efforts have been largely limited to components of brain biology that are affected by antidepressants and mood stabilizers. Microarray technology and genomic characterization represent new investigational developments that allow for unbiased identification of new molecular components and mechanisms of mood disorders. During the award period, the applicant aims to train in the application of microarrays to postmortem human brain studies, to initiate a genomic and molecular characterization of prefrontal cortex dysfunction in depressed patients who died by suicide, and to seek new mechanisms, genes and molecules that contribute to the development of the disease. Preliminary results indicate a rich potential for genomic approaches to psychiatric disorders and hints at a possible molecular classification of depression into unrecognized subtypes.
The specific aims of the study are /) to characterize gene expression profiles in the prefrontal cortex of human subjects, ii) to assess the effect of major depression and suicide on gene expression, iii) to investigate genes and molecular pathways that were affected by the disease, and iv) to develop new understanding of biological mechanisms involved in depression and suicide, with possibilities for designing new genetic mouse models, and uncovering new molecular targets for treatment and prevention of mood disorders. The proposed training plan will enable the applicant to benefit from recent advances in genome sequencing and genomic technologies, and to develop expertise to bridge these approaches to the study of neuropsychiatric disorders. In particular, the applicant will receive valuable training in genomics, statistics and bioinformatics, and in clinical and basic science aspects of brain function. The training program proposes formal courses, supervised training and frequent interactions with several research groups involved in pioneering aspects of genomic research in mood disorders. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01MH067721-06
Application #
7279200
Study Section
Special Emphasis Panel (ZRG1-BDCN-6 (01))
Program Officer
Wynne, Debra K
Project Start
2003-07-01
Project End
2008-08-31
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
6
Fiscal Year
2007
Total Cost
$161,002
Indirect Cost
Name
University of Pittsburgh
Department
Psychiatry
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Gunduz-Cinar, Ozge; Brockway, Emma; Lederle, Lauren et al. (2018) Identification of a novel gene regulating amygdala-mediated fear extinction. Mol Psychiatry :
Glorioso, Christin; Oh, Sunghee; Douillard, Gaelle Guilloux et al. (2011) Brain molecular aging, promotion of neurological disease and modulation by sirtuin 5 longevity gene polymorphism. Neurobiol Dis 41:279-90
Sibille, Etienne; Wang, Yingjie; Joeyen-Waldorf, Jennifer et al. (2009) A molecular signature of depression in the amygdala. Am J Psychiatry 166:1011-24
Surget, Alexandre; Wang, Yingjie; Leman, Samuel et al. (2009) Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 34:1363-80
Sibille, Etienne; Arango, Victoria; Joeyen-Waldorf, Jennifer et al. (2008) Large-scale estimates of cellular origins of mRNAs: enhancing the yield of transcriptome analyses. J Neurosci Methods 167:198-206
Sibille, E; Su, J; Leman, S et al. (2007) Lack of serotonin1B receptor expression leads to age-related motor dysfunction, early onset of brain molecular aging and reduced longevity. Mol Psychiatry 12:1042-56, 975
Barr, Gordon A; Gao, Puhong; Wang, Shaoning et al. (2005) Microarray analysis of gene expression following the formalin test in the infant rat. Pain 117:6-18
Erraji-Benchekroun, Loubna; Underwood, Mark D; Arango, Victoria et al. (2005) Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry 57:549-58
Pavlidis, Paul; Qin, Jie; Arango, Victoria et al. (2004) Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex. Neurochem Res 29:1213-22
Sibille, Etienne; Arango, Victoria; Galfalvy, Hanga C et al. (2004) Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology 29:351-61

Showing the most recent 10 out of 11 publications